Funding fit & go/no-go assessment
Evaluate program fit, mechanism, eligibility, scientific maturity, competitive positioning, and whether the opportunity warrants your company’s time and resources.
Menu
NIH SBIR/STTR
NIH SBIR/STTR strategy for biotech companies
NIH SBIR/STTR funding requires more than a strong scientific idea. Noradelis helps biotech companies evaluate funding fit, prepare for reviewer scrutiny, interpret feedback, and make better strategic decisions throughout the funding process.
NIH-focused support
Choose the support your next decision needs.
NIH SBIR/STTR decisions connect scientific maturity, mechanism and institute fit, milestones, and reviewer expectations. Our consulting brings these questions together at each stage.
Pre-submission review
An independent pre-submission review gives your team a reviewer-style assessment of scientific logic, positioning, likely reviewer questions, and major vulnerabilities while there is still time to revise.
Summary-statement & resubmission strategy
Interpret reviewer feedback, distinguish fixable weaknesses from strategic problems, and decide whether to resubmit, redirect, or stop.
Strategic advisory
Ongoing scientific and strategic support for recurring funding decisions: which opportunities to pursue, when the company is ready, and how reviewer feedback should change the plan.
A useful starting point
Bring the science, the opportunity, and the questions.
Helpful materials may include:
- The funding opportunity or mechanism under consideration
- A short technology or project summary and preliminary evidence
- Draft aims or an existing application
- Reviewer critiques for a resubmission
- Your target timeline and resource constraints
Explore NIH funding and guidance
Current opportunities · Application anatomy · After the summary statement · Foreign-risk and disclosure readiness
Your next funding decision
Discuss your funding strategy
Tell us what your company is pursuing, where you are in the process, and what decision or review you need help with.
Discuss your funding strategy